Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NASDAQ:HSDT

Solana Q3 2026 Earnings Date & Estimates

Solana logo
$2.26 -0.10 (-4.24%)
Closing price 10/22/2026 04:00 PM Eastern
Extended Trading
$2.28 +0.03 (+1.11%)
As of 08:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Solana is estimated to report Q3 2026 earnings on Tuesday, November 17, 2026. The conference call is scheduled for 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Conference Call
4:30 PM ET

What Analysts Expect from Solana in Q3 2026

Solana is expected to post earnings of $0.02 per share on revenue of $2.85 million. In the same quarter a year earlier Solana reported -$32.89 per share on revenue of $0.70 million. Solana last reported on August 14, 2026, posting -$0.38 per share and missing the -$0.02 consensus estimate. Solana has beaten the consensus EPS estimate in 3 of its last 5 quarters.

Consensus Estimates

Consensus EPS
$0.02
Expected Revenue
$2.85 million
Prior-Year EPS
-$32.89
Prior-Year Revenue
$0.70 million
Expected Revenue Growth
+308.9%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.38 (Missed by -$0.36)
Last Quarter Revenue
$2.53 million
EPS Beat Rate
3 of last 5 quarters

Solana Q3 2026 Earnings FAQ

Solana (NASDAQ:HSDT) is estimated to report Q3 2026 earnings on Tuesday, November 17, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Solana's Q3 2026 earnings conference call is scheduled for Tuesday, November 17, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Solana to post earnings of $0.02 per share for Q3 2026.

The consensus revenue estimate for Solana is $2.85 million for Q3 2026.

Solana Earnings Headlines

ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
See More Solana Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Solana? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solana and other key companies, straight to your email.

About Solana

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

View Solana Profile